KiResearcher
Protocols
Sexual healthIntermediate

Melanotan-2 for pigmentation and arousal

Melanotan-2 is a melanocortin-receptor agonist. Researchers study it for two effects, skin pigmentation through MC1R and sexual arousal through MC4R. It runs loading then maintenance.

Loading 1–2 weeks → maintenance · 4–6-week breaks

01

Why this protocol

Melanotan-2 activates the melanocortin receptors. Through MC1R it drives melanin production, the pigmentation effect. Through MC4R it influences sexual arousal pathways, the same route bremelanotide (PT-141) uses.

It runs loading then maintenance, a short daily loading phase to build the effect, then infrequent maintenance. Because melanocortin agonism desensitizes, it is pulsed with breaks rather than run continuously.

02

The regimen

Melanotan 2

Melanocortin agonist
Dose
0.25–0.5 mg (loading) → 0.5–1 mg (maintenance)
Schedule
Daily 1–2 wk (loading) → 1–2× weekly (maintenance) · subcutaneous
Timing
Evening; nausea/flushing are common early and ease with the lower maintenance dose
Reconstitution calculator

Reconstitution calculator

Calculated for a 1 mL U-100 insulin syringe (100 units/mL).

mg
mL

Units per dose

5 units

Draw this many units on a U-100 syringe

Each unit holds 50 mcg

Volume per dose
0.05 mL
Doses per vial
40
Concentration
5 mg/mL

One vial lasts

Daily
40 days
Every other day
80 days
5×/week
56 days

Research use only. Not for human consumption. Outputs are reference values based on research literature. Verify all measurements independently.

03

Cycle & schedule

  1. Loading (1–2 weeks)~0.25–0.5 mg once daily to build the effect. Start at the low end. Early nausea, flushing, and appetite changes are the common reasons people abandon it, and they ease at lower doses.
  2. Maintenance~0.5–1 mg once or twice weekly to hold the effect, rather than continued daily dosing.
  3. BreaksA minimum 4–6-week break comes before any subsequent cycle. MT-2 can darken existing moles and freckles. Anything that changes warrants a dermatologist's review.
04

Studies behind this protocol

This protocol composes the cited evidence on each peptide's page. See the full bibliography on: Melanotan 2.

Research use only · Not medical advice · Updated 2026-09-24